Acellular red blood cell substitute
AssigneeNorthfield Laboratories, Inc.
InventorsLakshman R. Sehgal, Richard E. De Woskin, Gerald S. Moss, Steven A. Gould, Arthur L. Rosen, Hansa Sehgal
Life of this patent
Estimating the term…
Abstract
An acellular red blood cell substitute which comprises an essentially tetramer-free, substantially stroma-free, cross-linked, polymerized, pyridoxylated hemoglobin and a nontoxic, pharmaceutically acceptable carrier, its use and a process for preparing said acellular red blood cell substitute.
Claims3
An aqueous solution of polymerized hemoglobin comprising from about 7-18 g/dL of essentially tetramer free, cross linked, polymerized hemoglobin derived from mammalian blood.
An aqueous solution of polymerized hemoglobin comprising from about 7-18 g/dL of essentially tetramer-free, substantially stroma-free, cross-linked, polymerized hemoglobin.
Dependencies are inferred from the claim text.